225 related articles for article (PubMed ID: 25814824)
1. CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.
Wang JC; Cao S; Wang A; To E; Law G; Gao J; Zhang D; Cui JZ; Matsubara JA
Mol Vis; 2015; 21():264-72. PubMed ID: 25814824
[TBL] [Abstract][Full Text] [Related]
2. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.
Johnson PT; Betts KE; Radeke MJ; Hageman GS; Anderson DH; Johnson LV
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17456-61. PubMed ID: 17079491
[TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.
Khandhadia S; Hakobyan S; Heng LZ; Gibson J; Adams DH; Alexander GJ; Gibson JM; Martin KR; Menon G; Nash K; Sivaprasad S; Ennis S; Cree AJ; Morgan BP; Lotery AJ
Ophthalmology; 2013 Aug; 120(8):1612-8. PubMed ID: 23562165
[TBL] [Abstract][Full Text] [Related]
4. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration.
Cao S; Ko A; Partanen M; Pakzad-Vaezi K; Merkur AB; Albiani DA; Kirker AW; Wang A; Cui JZ; Forooghian F; Matsubara JA
Am J Ophthalmol; 2013 Dec; 156(6):1176-83. PubMed ID: 24083687
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ
Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302
[TBL] [Abstract][Full Text] [Related]
6. Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration.
Lommatzsch A; Hermans P; Weber B; Pauleikhoff D
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1713-6. PubMed ID: 17704937
[TBL] [Abstract][Full Text] [Related]
7. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
[TBL] [Abstract][Full Text] [Related]
9. Interaction of complement factor h and fibulin3 in age-related macular degeneration.
Wyatt MK; Tsai JY; Mishra S; Campos M; Jaworski C; Fariss RN; Bernstein SL; Wistow G
PLoS One; 2013; 8(6):e68088. PubMed ID: 23840815
[TBL] [Abstract][Full Text] [Related]
10. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A
Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321
[TBL] [Abstract][Full Text] [Related]
11. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.
Seddon JM; George S; Rosner B; Klein ML
Hum Hered; 2006; 61(3):157-65. PubMed ID: 16816528
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
Loyet KM; Deforge LE; Katschke KJ; Diehl L; Graham RR; Pao L; Sturgeon L; Lewin-Koh SC; Hollyfield JG; van Lookeren Campagne M
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6628-37. PubMed ID: 22930722
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments.
Chen M; Forrester JV; Xu H
Exp Eye Res; 2007 Apr; 84(4):635-45. PubMed ID: 17292886
[TBL] [Abstract][Full Text] [Related]
14. Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.
Radu RA; Hu J; Jiang Z; Bok D
J Biol Chem; 2014 Mar; 289(13):9113-20. PubMed ID: 24550392
[TBL] [Abstract][Full Text] [Related]
15. Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy.
Nakanishi H; Yamashiro K; Yamada R; Gotoh N; Hayashi H; Nakata I; Saito M; Iida T; Oishi A; Kurimoto Y; Matsuo K; Tajima K; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6183-7. PubMed ID: 20688737
[TBL] [Abstract][Full Text] [Related]
16. The effect of photo-oxidative stress and inflammatory cytokine on complement factor H expression in retinal pigment epithelial cells.
Lau LI; Chiou SH; Liu CJ; Yen MY; Wei YH
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6832-41. PubMed ID: 21743006
[TBL] [Abstract][Full Text] [Related]
17. Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions.
Seitsonen S; Järvelä I; Meri S; Tommila P; Ranta P; Immonen I
Acta Ophthalmol; 2008 Jun; 86(4):390-4. PubMed ID: 17995985
[TBL] [Abstract][Full Text] [Related]
18. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
[TBL] [Abstract][Full Text] [Related]
19. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration.
Seitsonen SP; Jarvela IE; Meri S; Tommila PV; Ranta PH; Immonen IJ
Eur J Ophthalmol; 2007; 17(6):943-9. PubMed ID: 18050121
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
Bhutto IA; Baba T; Merges C; Juriasinghani V; McLeod DS; Lutty GA
Br J Ophthalmol; 2011 Sep; 95(9):1323-30. PubMed ID: 21633121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
